Business Wire

Karisma Hotels & Resorts to Open Holiday Villages Montenegro in Late Summer 2018

Jaa

Karisma Hotels & Resorts, an award-winning luxury hotel collection which owns and manages properties in Latin America, the Caribbean and Europe, is pleased to announce the opening of Holiday Villages Montenegro in late summer of 2018. Ideally situated on the serene Montenegrin coast of Ulcinj and featuring spectacular views of the Adriatic Sea, the stylish and upscale 257-room hotel blends modern convenience and elevated hospitality with effortless glamour, affording groups of all sizes an unparalleled European vacation experience.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180611006339/en/

Holiday Villages Montenegro (Photo: Business Wire)

Holiday Villages Montenegro (Photo: Business Wire)

Holiday Villages Montenegro offers a wide range of stylish and contemporary accommodations including substantial space for small or large families and welcoming amenities. Suites range from expansive two-bedroom swim-ups to garden view rooms with an inviting terrace and feature stunning views of the region’s immaculate lush palm trees. The property boasts four amazing restaurants with beautiful vistas and sophisticated culinary offerings, bringing together the best of Mediterranean and international cuisine. Guests can indulge in creative cocktails, prestigious wines, and the best beers from Montenegrin breweries at one of the six elevated bars.

In addition to its incredible locale just steps away from the stunning Ulcinj beaches comprised of flour-like sand, Holiday Villages Montenegro provides guests an array of fabulous wellness options including holistic spa treatments and a state-of-the-art fitness center, along with on-property activities such as tennis, football, an open-air playground, high ropes course, and kite surfing at the expansive Velika Plaža beach. Nightly professional entertainment is also provided at the resort’s open-air venue, which showcases a variety of performances like sing-alongs, acoustic concerts and family-themed shows.

“Holiday Villages Montenegro will mark the most luxurious hotel opening in Ulcinj yet,” said Armando Chomat, Chief Marketing Officer of Premier Worldwide Marketing, the exclusive worldwide representatives for Karisma Hotels & Resorts. “Blending exceptional hospitality with sophisticated dining and endless options for entertainment, we’re confident that Holiday Villages Montenegro will be the premier destination along the Adriatic coast for guests of all ages.”

Holiday Villages Montenegro is located along the majestic Long Beach (Velika Plaža) just 5 km from the historic town of Ulcinj, a popular summer destination known for its sandy beaches that are considered the most beautiful in Montenegro. The hotel’s prime location affords guests access to the vibrant downtown area with countless sightseeing options including historic churches, mosques, museums, atmospheric cafes and the best spots to savor sunsets. Also in close proximity are distinguished landmarks including the island of Ada Bojana, Lake Skadar and the Ulcinj Salinas Bird Reserve, which is home to incredible birds of prey, Dalmatian pelicans and flamingos. The closest airports to the hotel are in Podgorica and Tivat, approximately 80 km away.

Holiday Villages Montenegro is now available for bookings for stays starting in late summer 2018. Rates start at $152 per night and represent a savings of up to 20 percent as part of the grand opening special. Reservations can be made by calling 1-866-527-4762 or visiting http://karismaadriatic.com/Hotels-Resorts/Holiday-Villages-Montenegro/.

About Karisma Hotels & Resorts

Karisma Hotels & Resorts, an award-winning luxury hotel collection which owns and manages properties in Latin America, the Caribbean and Europe, comprises an impressive portfolio including El Dorado Spa Resorts by Karisma, Azul Beach Resorts by Karisma, Generations Resorts by Karisma, Karisma Villas, Allure Hotels by Karisma, Hidden Beach Resort by Karisma, Nickelodeon Hotels & Resorts, Sensatori Resorts, Sensimar Resorts, and Karisma Hotels Adriatic. Properties have been honored with the industry’s top accolades including Conde Nast Traveler’s “Top 100 Hotels in the World,” Conde Nast Traveler’s “Top 30 Hotels in Cancun,” TripAdvisor® Traveler’s Choice “Best Hotels for Romance,” and AAA’s “Five Diamond Award” and “Four Diamond Award.” Karisma has received worldwide recognition for its creative approach to hospitality management and product innovations. For reservations and a full list of Karisma properties, please visit www.karismahotels.com.

Contact information

J. Wade Public Relations
Jenn Wade, Nicole Lax, Yasmin Imam, Blake Willahan, Megan Zamiska or Julia Gonsalves, 415-325-5519
karismapr@jwadepr.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista jo ennen kuin ne uutisoidaan? Kun tilaat tiedotteemme, saat ne sähköpostiisi yhtä aikaa suomalaisen median kanssa. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Emmaus Life Sciences Announces the New England Journal of Medicine has Published the Phase 3 Trial Results of Endari™ (L-Glutamine Oral Powder) in Sickle Cell Disease19.7.2018 00:45Tiedote

VIEW E-MEDIA KIT – Emmaus Life Sciences, Inc. (Emmaus) announced today that the New England Journal of Medicine (NEJM) has published the results of its 48-week phase 3 clinical trial of Endari™ (L-glutamine oral powder) which supported the FDA approval in July 2017 to reduce the acute complications of sickle cell disease in adult and pediatric patients 5 years of age and older. The article reports results that showed significantly fewer sickle cell crises in those receiving Endari compared to placebo by 25 percent; p=0.005 (median 3 vs. median 4) and significantly fewer hospitalizations by 33 percent; p=0.005 (median 2 vs. median 3). Additional findings showed lower cumulative days in hospital of 41 percent; p=0.02 (median 6.5 days vs. median 11 days) and a lower incidence of acute chest syndrome (ACS) by more than 60 percent; p=0.003 (13 of 152 patients [8.6%] had at least 1 ACS compared with 18 of 78 in the placebo group [23.1%]). The most common adverse reactions, occurring in great

Tigo Releases State-of-the-art Wireless Technology – Mesh – as the New Solar Communication Architecture for the TS4 Platform18.7.2018 22:41Tiedote

Tigo®, pioneer of the smart modular Flex MLPE platform, today announced the release of its new Mesh communication architecture. This state-of-the-art wireless technology directly translates to customer benefits – including simplifying the solar design process and accelerating the commissioning steps. The complete Tigo solution uses a simple yet powerful data collection technology that covers the widest ranges of residential & commercial installations at the lowest cost. With Mesh and the recently announced Tigo Access Point (TAP), customers eliminate the need to address any roof obstruction or orientation constraint. To learn more about Mesh and TAP, register for Tigo’s free, online webinar “The Future of Solar is Wireless” on Wednesday July 25th, 2018 at 10am PDT. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180718005827/en/ Mesh is Tigo's proprietary software that allows each TS4 unit to act as a repeater, extending the

ViiV Healthcare Shares Data from Landmark 2-Drug Regimen Trials At AIDS 201818.7.2018 20:21Tiedote

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer Inc. and Shionogi Limited as shareholders, will be presenting over 20 abstracts, including data from the landmark GEMINI 1 & 2 clinical trials, at the 22nd International AIDS Conference (AIDS 2018), 23-27 July 2018, in Amsterdam, The Netherlands. The data being presented this year has a strong focus on novel exploratory therapeutic options and innovative treatment strategies, as well as improving awareness and understanding of key issues that continue to affect the HIV community. John C Pottage, Jr, MD, Chief Scientific and Medical Officer, ViiV Healthcare, commented, “As we see advancements in the treatment options available to people living with HIV, our research efforts over the past few years have been focused on moving beyond viral load and addressing some of the unresolved issues that people living with HIV face, such as the potential long-term risks and toxicities that can be associated with li

Xilam: H1 2018 Revenue: +50%18.7.2018 19:00Tiedote

Regulatory News: The Xilam Group (Paris:XIL) posted consolidated H1 2018 revenue of EUR 13,866 thousand, an increase of 50%. This increase represents an excellent performance, as it follows on the heels of growth of 54% in H1 2017. Revenue for the first part of this financial year breaks down as follows. In thousands of euros 30.06.2018 (1) 30.06.2017 Change New productions 8,465 4,571 +85% Catalogue 5,385 4,652 +16% Other 16 16 +0% Revenue and subsidies 13,866 9,239 +50% (1) Unaudited data. Remarkable success for new releases +85% Excellent H1 growth was driven by the two main businesses, New Productions and Catalogue. In New Productions, H1 deliveries generated record revenue of EUR 8,465 thousand, an 85% increase compared with H1 2017, and confirmed Xilam’s position as a major European animation company. Catalogue revenue was up 16% compared with H1 2017, thanks again to traditional TV channels and digital platforms, in both France and abroad. A fast-paced delivery schedule Thanks t

Department for International Trade: Life Sciences at the Heart of UK Economy18.7.2018 15:38Tiedote

The Government will today (Wednesday 18 July) host the second in a series of roundtables with stakeholders from key life science businesses, demonstrating the importance of the sector to the UK economy. The Chancellor, International Trade Secretary, Business Secretary and Health and Social Care Secretary will be amongst those that meet with senior representatives from leading UK and international life sciences companies as the UK positions itself as the global home of health innovation, welcoming overseas investment and seeking to boost exports in the process. Discussions at the roundtable will focus on how the future of the Life Sciences sector will be supported by the delivery of our modern Industrial Strategy, ensuring that the UK is ‘open for business’ with a positive business environment, our ambitions for a comprehensive agreement with the EU on our future relationship and the development and implementation of our independent trade policy. To date, the government has engaged sign

Universal Laser Systems Expands Its Materials Database with 3M, Victrex and Dexmet Materials18.7.2018 15:05Tiedote

Universal Laser Systems (ULS) announces the addition of 3M™, Victrex® and Dexmet materials to its materials database, the most extensive repository of laser material processing parameters for materials in the range of 10 watts to 500 watts. The 3M, Victrex and Dexmet materials new to the ULS materials database were specifically added for laser processing with the ULTRA and XLS platforms, suited for high accuracy and precision laser cutting, laser ablation and laser surface modification. The materials include: 3M™ Extreme Sealing Tape 4412N 3M™ Thermally Conductive Silicone Interface Pad 5516 Victrex® APTIV® PEEK Film Dexmet PolyGrid® 8PTFE10-125ST Expanded PTFE Dexmet MicroGrid® AL 25 Expanded Aluminum Laser processing notes, describing the results of the laser-material interaction for these materials, are also available in the Materials Library on the ULS website to help potential customers explore the advantages of deploying laser technology within their manufacturing, research and d

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme